2025 M&A Report

2025 M&A Report

Publication

This year’s M&A Report offers a detailed review of the M&A market and outlook, including a breakdown by various geographies and industry sectors. We examine what might be in store with antitrust and CFIUS under the Trump Administration, common purchase price adjustments in financial services transactions, and common takeover defenses.

We also look at considerations in conducting “dual track” M&A and IPO processes and the challenges associated with pursuing pre-IPO acquisitions. Finally, we review trends in VC-backed company M&A deal terms.

The following information is a snapshot of this year’s report, we invite you to read the full report, our IPO Report and our Venture Capital Report. Please stay in touch with us by subscribing to Material: WilmerHale’s M&A blog and our mailing lists so you can stay up to date on the latest developments related to M&A.

Market Review and Outlook

Entering 2024, the anticipation had been that the macroeconomic headwinds that prevailed since 2022 would begin to dissipate, and M&A activity would start to see a resurgence. Instead, continued high interest rates, economic uncertainty, heightened regulatory scrutiny, and the valuation gap between buyers and sellers prevailed throughout much of the year, resulting in only a modest M&A market recovery that fell meaningfully short of achieving recent historical levels.

Publication-2025M&AReport-GlobalM&A-Activity-Chart
Publication-2025M&AReport-USM&AActivity-Chart

Featured Articles

Expand All Collapse All

Contributors

Stay current on our Insights & News.

Researchers

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.